Risk factors for postoperative intensive care unit admission after minimally invasive esophagectomy following neoadjuvant chemoimmunotherapy in patients with esophageal squamous cell carcinoma: a retrospective cohort study
Introduction Patients with esophageal squamous cell carcinoma (ESCC) who undergo minimally invasive esophagectomy (MIE) after neoadjuvant chemoimmunotherapy (nCIT) and subsequently require postoperative intensive care unit (ICU) admission may experience a greater economic burden and poorer clinical outcomes. This study...